Carmel Capital Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.07M Buy
11,493
+2,845
+33% +$770K 1.11% 25
2025
Q4
$2.17M Buy
8,648
+2,627
+44% +$698K 0.76% 49
2025
Q3
$1.73M Sell
6,021
-1,519
-20% -$407K 0.73% 33
2025
Q2
$1.98M Buy
7,540
+759
+11% +$185K 0.69% 41
2025
Q1
$1.58M Buy
6,781
+176
+3% +$42.7K 0.62% 37
2024
Q4
$1.51M Buy
6,605
+547
+9% +$125K 0.61% 36
2024
Q3
$1.35M Sell
6,058
-129
-2% -$28.4K 0.52% 38
2024
Q2
$1.26M Buy
6,187
+1,035
+20% +$211K 0.53% 38
2024
Q1
$1.13M Buy
5,152
+70
+1% +$15.4K 0.47% 42
2023
Q4
$1.16M Buy
5,082
+37
+0.7% +$7.77K 0.59% 34
2023
Q3
$1.01M Sell
5,045
-1,429
-22% -$301K 0.46% 45
2023
Q2
$1.34M Buy
6,474
+646
+11% +$125K 0.69% 32
2023
Q1
$1.15M Buy
5,828
+236
+4% +$48.6K 0.68% 28
2022
Q4
$1.13M Sell
5,592
-218
-4% -$42.6K 0.78% 23
2022
Q3
$1.02M Sell
5,810
-821
-12% -$168K 0.99% 22
2022
Q2
$1.33M Buy
6,631
+499
+8% +$106K 1.25% 11
2022
Q1
$1.39M Buy
6,132
+94
+2% +$22.1K 1.16% 16
2021
Q4
$1.63M Buy
+6,038
New +$1.49M 1.22% 13

Other funds holding LH

Carmel Capital Partners's LH Position: Q1 2026 in Review

Carmel Capital Partners increased its Labcorp (LH) stake by 33% in Q1 2026, buying an estimated $770K and bringing the position to 11,493 shares worth $3.07M. The position accounts for 1.11% of the portfolio, ranked #25.

Carmel Capital Partners first reported a position in LH in Q4 2021 and has held it in 18 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Carmel Capital Partners held 11,493 shares of Labcorp worth $3.07M as of Q1 2026.
  • Carmel Capital Partners bought 2,845 Labcorp shares in Q1 2026, an estimated $770K.
  • Labcorp made up 1.11% of Carmel Capital Partners's portfolio in Q1 2026, its #25 holding.
  • Carmel Capital Partners first reported a position in Labcorp in Q4 2021 and has held it in 18 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Carmel Capital Partners's 13F filing for Q1 2026, filed 30 Apr 2026.